semaglutide fda submission Semaglutide: The Drug of Today and a Steppingstone to Tomorrow FDA ends semaglutide shortage, closing

HRS9531 achieves significant weight reduction in Phase 3 trial, with plans for NDA submission in China and global development as KAI-9531

The Human C-peptide Ultrasensitive ELISA Kit is intended for use in the quantitative determination of human connecting peptide in serum and/or plasma

Reglerar blodsocker & minskar aptit

Very well written and comprehensive comparison Very informative table for RWE studies comparing tirzepoatide vs semaglutide The only addition/correction I would make is that both tirzepatide and semaglutide have trials in patients with HFpEF and both with very positive results #tirzepatide #semaglutide #obesity #type2diabetes #cardiovascularcomplications #rwe

Smaller meals shouldn't mean fewer nutrients